Welcome to Dividends Inside
Welcome to Dividends Inside!

The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.

Franklin Genomic Advancements ETF

HELX
$32.67 (+ $0.14 + 0.44%)
Last updated: 2026-05-20 10:47 UTC
HELX Metrics
Exchange
🇺🇸 CBOE BATS
CBOE BZX U.S. Equities ExchangeUnited StatesAmerica/New_York
SectorHealth
IndustryFranklin Templeton Investments
ISINUS35473P5200
Market Price32.67
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyYearly
P/E Ratio31.83
EPS1.17
Market CapN/A
Book ValueN/A
Price to BookN/A
BetaN/A
52w High38.11
52w Low23.74
Next Earnings DateN/A
About the Company
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Price History